Skip to content

Apotheek Schockaert M.: what changed

BE 0824.313.126NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€19,059
2024 · €15,093+€3,966
Equity
€119,990
2024 · €100,931+€19,059
Cash
€80,892
2024 · €88,093-€7,201
Balance sheet total
€473,175
2024 · €413,883+€59,292

Largest movements

2024 to 2025
Assets
  • Current investments +€38,473

    up €38,473 (+33.4%), from €115,113 to €153,587

  • Stocks and contracts +€27,272

    up €27,272 (+18.7%), from €145,652 to €172,924

  • Receivables within one year +€19,754

    up €19,754 (+47.3%), from €41,776 to €61,530

    of which Trade receivables: +€18,792

  • Tangible fixed assets -€18,985

    down €18,985 (-94.0%), from €20,199 to €1,214

    of which Plant, machinery and equipment: -€16,820

  • Cash -€7,201

    down €7,201 (-8.2%), from €88,093 to €80,892

    mainly Current investments (-€38,473) and Stocks and contracts (-€27,272)

Equity and liabilities
  • Trade debts +€27,737

    up €27,737 (+62.6%), from €44,300 to €72,036

  • Profit (loss) carried forward +€19,059

    up €19,059 (+30,090%), from €63 to €19,122

  • Advances received +€7,939

    new in 2025: €7,939

  • Other debts +€5,766

    up €5,766 (+3.5%), from €162,425 to €168,191

Income statement
  • Gross operating margin +€2,198

    up €2,198 (+4.9%), from €44,905 to €47,103

  • Financial income +€2,039

    up €2,039 (+332%), from €614 to €2,653

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €15,093
Gross operating margin +€2,198
Depreciation +€0
Other operating charges -€16
Financial income +€2,039
Financial charges -€254
Result 2025 €19,059
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€31,272
Investment -€38,473
Financing €0
Cash 2024 €88,093
Net result for the year +€19,059
Depreciation +€18,985
Stocks and contracts -€27,272
Receivables within one year -€19,754
Deferred charges and accrued income +€21
Trade debts +€27,737
Tax, wage and social debts -€1,209
Advances received +€7,939
Other debts +€5,766
Current investments -€38,473
Cash 2025 €80,892
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €413,883 €473,175 +€59,292 +14.3%
Fixed assets 21/28 €21,806 €2,820 -€18,985 -87.1%
Tangible fixed assets 22/27 €20,199 €1,214 -€18,985 -94.0%
Plant, machinery and equipment 23 €17,252 €432 -€16,820 -97.5%
Furniture and vehicles 24 €2,947 €782 -€2,165 -73.5%
Financial fixed assets 28 €1,606 €1,606 = 0.0%
Current assets 29/58 €392,078 €470,355 +€78,277 +20.0%
Stocks and contracts in progress 3 €145,652 €172,924 +€27,272 +18.7%
Stocks 30/36 €145,652 €172,924 +€27,272 +18.7%
Amounts receivable within one year 40/41 €41,776 €61,530 +€19,754 +47.3%
Trade receivables 40 €39,897 €58,689 +€18,792 +47.1%
Other amounts receivable 41 €1,879 €2,842 +€963 +51.2%
Current investments 50/53 €115,113 €153,587 +€38,473 +33.4%
Cash at bank and in hand 54/58 €88,093 €80,892 -€7,201 -8.2%
Deferred charges and accrued income 490/1 €1,443 €1,422 -€21 -1.5%
Total equity and liabilities 10/49 €413,883 €473,175 +€59,292 +14.3%
Equity 10/15 €100,931 €119,990 +€19,059 +18.9%
Contributions 10/11 €100,000 €100,000 = 0.0%
Reserves 13 €868 €868 = 0.0%
Tax-exempt reserves 132 €868 €868 = 0.0%
Profit (loss) carried forward 14 €63 €19,122 +€19,059 +30,090%
Amounts payable 17/49 €312,952 €353,185 +€40,233 +12.9%
Amounts payable after more than one year 17 €100,000 €100,000 = 0.0%
Financial debts 170/4 €100,000 €100,000 = 0.0%
Amounts payable within one year 42/48 €207,952 €248,185 +€40,233 +19.3%
Trade debts 44 €44,300 €72,036 +€27,737 +62.6%
Suppliers 440/4 €44,300 €72,036 +€27,737 +62.6%
Advances received on contracts in progress 46 - €7,939 +€7,939
Taxes, remuneration and social security 45 €1,227 €18 -€1,209 -98.5%
Taxes 450/3 €1,227 €18 -€1,209 -98.5%
Other amounts payable 47/48 €162,425 €168,191 +€5,766 +3.5%
Accrued charges and deferred income 492/3 €5,000 €5,000 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,985 €18,985 -€0 0.0%
Other operating charges 640/8 €556 €572 +€16 +2.9%
Gross operating margin 9900 €44,905 €47,103 +€2,198 +4.9%
Operating profit (loss) 9901 €25,364 €27,546 +€2,182 +8.6%
Financial income 75/76B €614 €2,653 +€2,039 +332%
Recurring financial income 75 €614 €2,653 +€2,039 +332%
Financial charges 65/66B €10,885 €11,139 +€254 +2.3%
Recurring financial charges 65 €10,885 €11,139 +€254 +2.3%
Profit (loss) for the period before taxes 9903 €15,093 €19,059 +€3,966 +26.3%
Profit (loss) for the period 9904 €15,093 €19,059 +€3,966 +26.3%
Profit (loss) for the period to be appropriated 9905 €15,093 €19,059 +€3,966 +26.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€127,881 to €155,035

Midpoint €139,195 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €119,990
Capitalised earnings €135,771 to €190,080
Indication €127,881 to €155,035

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€119,990
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€119,990

Capitalised earnings

net result for the year (9904)
2025
€19,059
2024
€15,093
2023
€22,872
2022
-€2,216
2021
-€9,215
Average result
€19,008
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€135,771 / €158,400 / €190,080

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.